{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:53:54Z","timestamp":1793336034949,"version":"4.5.0"},"reference-count":38,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"unspecified","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute for Health Research (NIHR) Clinical Doctoral Research Fellowship","award":["ICA-CDRF-2015-01-0120"],"award-info":[{"award-number":["ICA-CDRF-2015-01-0120"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,11,19]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To report the 12-month prevalence of joint bleeds from the National Haemophilia Database (NHD) and Haemtrack, a patient-reported online treatment diary and concurrent joint disease status using the haemophilia joint health score (HJHS) at individual joint level, in children and adults with severe haemophilia A and B (HA\/HB) without a current inhibitor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A 2018 retrospective database study of NHD from which 2238 cases were identified, 463 patients had fully itemised HJHS of whom 273 were compliant in recording treatment using Haemtrack.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>England, Wales and Scotland, UK.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Children (&lt;18 years) and adults (\u226518 years) with severe HA and HB (factor VIII\/factor IX, &lt;0.01 iu\/mL) without a current inhibitor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcomes<\/jats:title>\n                    <jats:p>Prevalence of joint haemarthrosis and concurrent joint health measured using the HJHS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median (IQR) age of children was 10 (6\u201313) and adults 40 (29\u201350) years. Haemarthrosis prevalence in HA\/HB children was 33% and 47%, respectively, and 60% and 42%, respectively, in adults. The most common site of haemarthrosis in children was the knee in HA and ankle in HB. In adults, the incidence of haemarthrosis at the ankles and elbows was equal. The median total HJHS in HA\/HB children was 0 and in adults with HA\/HB, were 18 and 11, respectively. In adults with HA\/HB, the median ankle HJHS of 4.0 was higher than the median HJHS of 1.0 for both the knee and elbow.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite therapeutic advances, only two-thirds of children and one-third of adults were bleed-free, even in a UK cohort selected for high compliance with prophylaxis. The median HJHS of zero in children suggests joint health is relatively unaffected during childhood. In adults, bleed rates were highest in ankles and elbows, but the ankles led to substantially worse joint health scores.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-052358","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T11:50:50Z","timestamp":1641988250000},"page":"e052358","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["Twelve-month prevalence of haemarthrosis and joint disease using the Haemophilia Joint Health score: evaluation of the UK National Haemophilia Database and Haemtrack patient reported data: an observational study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1885-5472","authenticated-orcid":false,"given":"Richard A","family":"Wilkins","sequence":"first","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK"},{"name":"Leeds Haemophilia Comprehensive Care Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-3343","authenticated-orcid":false,"given":"David","family":"Stephensen","sequence":"additional","affiliation":[{"name":"Haemophilia Centre, East Kent Hospitals University NHS Foundation Trust, Canterbury, UK"},{"name":"Haemophilia Centre, Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Siddle","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J","family":"Scott","sequence":"additional","affiliation":[{"name":"University Department of Clinical Haematology, Manchester Royal Infirmary, Manchester, UK"},{"name":"Institute of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Xiang","sequence":"additional","affiliation":[{"name":"National Haemophilia Database, United Kingdom Haemophilia Centre Doctors\u2019 Organisation (UKHCDO), Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Horn","sequence":"additional","affiliation":[{"name":"Leeds Haemophilia Comprehensive Care Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Palmer","sequence":"additional","affiliation":[{"name":"National Haemophilia Database, United Kingdom Haemophilia Centre Doctors\u2019 Organisation (UKHCDO), Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham J","family":"Chapman","sequence":"additional","affiliation":[{"name":"School of Sport and Health Sciences, University of Central Lancashire, Preston, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Richards","sequence":"additional","affiliation":[{"name":"Leeds Haemophilia Comprehensive Care Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Walwyn","sequence":"additional","affiliation":[{"name":"Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Redmond","sequence":"additional","affiliation":[{"name":"NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"key":"2025121222312208000_12.1.e052358.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13405-8"},{"key":"2025121222312208000_12.1.e052358.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1958.tb03830.x"},{"key":"2025121222312208000_12.1.e052358.3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/hae.12375","article-title":"The burden of bleeding in haemophilia: is one bleed too many?","volume":"20","author":"Gringeri","year":"2014","journal-title":"Haemophilia"},{"key":"2025121222312208000_12.1.e052358.4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/hae.13449","article-title":"Joint disease in haemophilia: pathophysiology, pain and imaging","volume":"24 Suppl 6","author":"van Vulpen","year":"2018","journal-title":"Haemophilia"},{"key":"2025121222312208000_12.1.e052358.5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2516.2006.01268.x","article-title":"Pathogenesis of haemophilic arthropathy","volume":"12 Suppl 3","author":"Roosendaal","year":"2006","journal-title":"Haemophilia"},{"key":"2025121222312208000_12.1.e052358.6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/hae.13201","article-title":"Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia","volume":"23","author":"Hanley","year":"2017","journal-title":"Haemophilia"},{"key":"2025121222312208000_12.1.e052358.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067659"},{"key":"2025121222312208000_12.1.e052358.8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-528414"},{"key":"2025121222312208000_12.1.e052358.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04214.x"},{"key":"2025121222312208000_12.1.e052358.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2012.02909.x"},{"key":"2025121222312208000_12.1.e052358.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03650.x"},{"key":"2025121222312208000_12.1.e052358.12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/hae.13862","article-title":"Achieving the unimaginable: health equity in haemophilia","volume":"26","author":"Skinner","year":"2020","journal-title":"Haemophilia"},{"key":"2025121222312208000_12.1.e052358.13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2516.2012.02822.x","article-title":"WFH: closing the global gap--achieving optimal care","volume":"18 Suppl 4","author":"Skinner","year":"2012","journal-title":"Haemophilia"},{"key":"2025121222312208000_12.1.e052358.14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/hae.13877","article-title":"Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors","volume":"26","author":"Ebbert","year":"2020","journal-title":"Haemophilia"},{"key":"2025121222312208000_12.1.e052358.15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.thromres.2019.12.012","article-title":"Extended half-life recombinant products in haemophilia clinical practice - Expectations, opportunities and challenges","volume":"196","author":"Chowdary","year":"2020","journal-title":"Thromb Res"},{"key":"2025121222312208000_12.1.e052358.16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/hae.13616","article-title":"Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: the THUNDER study","volume":"25","author":"Scott","year":"2019","journal-title":"Haemophilia"},{"key":"2025121222312208000_12.1.e052358.17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/hae.13111","article-title":"European retrospective study of real-life haemophilia treatment","volume":"23","author":"Berntorp","year":"2017","journal-title":"Haemophilia"},{"key":"2025121222312208000_12.1.e052358.18","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/hae.13023","article-title":"Correlating clinical and radiological assessment of joints in haemophilia: results of a cross sectional study","volume":"22","author":"Poonnoose","year":"2016","journal-title":"Haemophilia"},{"key":"2025121222312208000_12.1.e052358.19","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2147\/PPA.S139851","article-title":"Duncan, and adherence, treatment adherence in hemophilia","volume":"11","author":"Thornburg","year":"2017","journal-title":"Patient preference adherence"},{"key":"2025121222312208000_12.1.e052358.20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/hae.13287","article-title":"The haemtrack home therapy reporting system: design, implementation, strengths and weaknesses: a report from UK haemophilia centre doctors organisation","volume":"23","author":"Hay","year":"2017","journal-title":"Haemophilia"},{"key":"2025121222312208000_12.1.e052358.21","unstructured":"UKHCDO . United Kingdom haemophilia centre doctors organisation, 2020. Available: http:\/\/www.ukhcdo.org\/nhd\/ [Accessed 05 Apr 2020]."},{"key":"2025121222312208000_12.1.e052358.22","unstructured":"UKHCDO . UKHCDO annual report 2019, including bleeding disorder statistics, 2019."},{"key":"2025121222312208000_12.1.e052358.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08139.x"},{"key":"2025121222312208000_12.1.e052358.24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/ejh.12369","article-title":"Outcome measures in haemophilia: a systematic review","volume":"93","author":"Boehlen","year":"2014","journal-title":"Eur J Haematol"},{"key":"2025121222312208000_12.1.e052358.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01312.x"},{"key":"2025121222312208000_12.1.e052358.26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/21679169.2018.1438511","article-title":"Comparison of joint status in children with haemophilia a using ultrasound and physical examination","volume":"20","author":"Aspdahl","year":"2018","journal-title":"Eur J Physiother"},{"key":"2025121222312208000_12.1.e052358.27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4231"},{"key":"2025121222312208000_12.1.e052358.28","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199905)42:5<1033::AID-ANR24>3.0.CO;2-#"},{"key":"2025121222312208000_12.1.e052358.29","first-page":"339","article-title":"Blood-induced joint damage: longterm effects in vitro and in vivo","volume":"30","author":"Hooiveld","year":"2003","journal-title":"J Rheumatol"},{"key":"2025121222312208000_12.1.e052358.30","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2516.2008.01720.x","article-title":"Orthopaedic management of haemophilia arthropathy of the ankle","volume":"14 Suppl 3","author":"Pasta","year":"2008","journal-title":"Haemophilia"},{"key":"2025121222312208000_12.1.e052358.31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/1871529X17666170908110758","article-title":"Management of hemophilic arthropathy of the ankle","volume":"17","author":"Rodriguez-Merchan","year":"2017","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"2025121222312208000_12.1.e052358.32","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12133"},{"key":"2025121222312208000_12.1.e052358.33","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1016\/S2352-3026(18)30048-6","article-title":"Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian hemophilia prophylaxis study longitudinal cohort","volume":"5","author":"Feldman","year":"2018","journal-title":"Lancet Haematol"},{"key":"2025121222312208000_12.1.e052358.34","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/hae.13327","article-title":"Monitoring joint health in haemophilia: factors associated with deterioration","volume":"23","author":"Kuijlaars","year":"2017","journal-title":"Haemophilia"},{"key":"2025121222312208000_12.1.e052358.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03767.x"},{"key":"2025121222312208000_12.1.e052358.36","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.221093"},{"key":"2025121222312208000_12.1.e052358.37","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.133462"},{"key":"2025121222312208000_12.1.e052358.38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/hae.12755","article-title":"Using routine haemophilia joint health score for international comparisons of haemophilia outcome: standardization is needed","volume":"22","author":"Nijdam","year":"2016","journal-title":"Haemophilia"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-052358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:31:31Z","timestamp":1765607491000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-052358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,12]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/bmjopen-2021-052358"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-052358","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-111806\/v1","asserted-by":"object"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}